CASCADE FH Registry: Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia
-
- STATUS
- Recruiting
-
- sponsor
- The FH Foundation
Summary
CASCADE FH Registry: Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia
Description
The purpose of this registry is to collect and maintain clinical information about patients that have been diagnosed with Familial Hypercholesterolemia (FH). The information will be used to look at current treatment, events, and outcomes of these patients. This will help further the understanding of the disease and improve care, quality of life, and survival of patients with FH.
FH is a common genetic condition that occurs in approximately 1 in 300-500 individuals. FH is characterized by a dramatically high level of LDL-C, which is not related to diet or lifestyle. Because of a life long burden of high cholesterol levels, young individuals with FH have a greater risk of coronary disease compared to the general population. FH is genetically inherited, and if one person is diagnosed with FH, his/her family members should also be screened.
By participating in the CASCADE Registry, the study staff will have access to the participants’ medical records. The study staff will collect information such as the medical history, procedures, laboratory results, and current medications from the participants’ medical records. There is no limit on the length of time participants will be in the study; participants will be in the registry as long as it remains open, or the participant decides to stop taking part of the registry.
There is no guarantee that participants will receive direct benefit from this study. However, participation in this study may help others get a better treatment for their FH in the future, and allow researchers to learn more about the management of FH and promote awareness for FH.
For more information, please contact:Nelson Chen, CRC
646-317-0785
nec9039@nyp.org
Details
| Condition | Familial Hypercholesterolemia |
|---|---|
| Clinical Study Identifier | TX150277 |
| Sponsor | The FH Foundation |
| Last Modified on | 23 November 2020 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer